Anti-CHRNB1 Antibody

Raised in rabbit hosts, this polyclonal reagent targets the cholinergic receptor nicotinic beta 1 subunit and is supplied as an unconjugated preparation by Antibodies.com. The 100 µl volume supports multiple Western blot and immunohistochemistry runs, with validated reactivity against human, mouse, and rat samples. CHRNB1 contributes to the muscle-type nicotinic acetylcholine receptor complex at the neuromuscular junction, making it relevant to research on congenital myasthenic syndrome, motor endplate biology, and cholinergic signaling. As a polyclonal antibody, it recognizes multiple epitopes on the target protein, improving signal reliability in both tissue section staining and lysate-based detection workflows. Refrigerated storage in single-use aliquots helps preserve binding activity across repeated experimental cycles, and the unconjugated format allows flexible conjugation to fluorophores or enzymes in custom assay setups. Intended for research use only, the reagent fits neuroscience, muscle physiology, and receptor pharmacology studies.